Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 240

The DOI matches its Crossref record.

Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide

Open access
Wu, Chang-Jer, Jan, Jia-Tsrong, Chen, Chi-Min, Hsieh, Hsing-Pang, Hwang, Der-Ren, Liu, Hwan-Wun, Liu, Chiu-Yi, Huang, Hui-Wen, Chen, Su-Chin, Hong, Cheng-Fong, Lin, Ren-Kuo, Chao, Yu-Sheng, Hsu, John T. A.·2004·Antimicrobial Agents and Chemotherapy

Abstract

Antiviral agents are urgently needed to fight severe acute respiratory syndrome (SARS). We showed that niclosamide, an existing antihelminthic drug, was able to inhibit replication of a newly discovered coronavirus, SARS-CoV; viral antigen synthesis was totally abolished at a niclosamide concentration of 1.56 μM, as revealed by immunoblot analysis. Thus, niclosamide represents a promising drug candidate for the effective treatment of SARS-CoV infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.48.7.2693-2696.2004

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 240

Metadata

Authors
Wu, C.-J., Jan, J.-T., Chen, C.-M., Hsieh, H.-P., Hwang, D.-R., Liu, H.-W., Liu, C.-Y., Huang, H.-W., Chen, S.-C., Hong, C.-F., Lin, R.-K., Chao, Y.-S., & Hsu, J. T. A.
Venue
Antimicrobial Agents and Chemotherapy
Published
2004-07
Volume
48
Issue
7
Pages
2693-2696
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2144030492
Cited by
240
References
0
FWCI
5.08
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide. https://app.cochat.ai/papers/10.1128/aac.48.7.2693-2696.2004
The paper
Wu, C.-J., Jan, J.-T., Chen, C.-M., Hsieh, H.-P., Hwang, D.-R., Liu, H.-W., Liu, C.-Y., Huang, H.-W., Chen, S.-C., Hong, C.-F., Lin, R.-K., Chao, Y.-S., & Hsu, J. T. A. (2004). Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.48.7.2693-2696.2004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.